Artificial Intelligence for Clinical Prediction: Exploring Key Domains and Essential Functions

Abstract

Background

Clinical prediction is integral to modern healthcare, leveraging current and historical medical data to forecast health outcomes. The integration of Artificial Intelligence (AI) in this field significantly enhances diagnostic accuracy, treatment planning, disease prevention, and personalised care leading to better patient outcomes and healthcare efficiency.

Methods

This systematic review implemented a structured four-step methodology, including an extensive literature search in academic databases (PubMed, Embase, Google Scholar), applying specific inclusion and exclusion criteria, data extraction focusing on AI techniques and their applications in clinical prediction, and a thorough analysis of the collected information to understand AI's roles in enhancing clinical prediction.

Results

Through the analysis of 74 experimental studies, eight key domains, where AI significantly enhances clinical prediction, were identified: (1) Diagnosis and early detection of disease; (2) Prognosis of disease course and outcomes; (3) Risk assessment of future disease; (4) Treatment response for personalised medicine; (5) Disease progression; (6) Readmission risks; (7) Complication risks; and (8) Mortality prediction. Oncology and radiology come on top of the specialties benefiting from AI in clinical prediction.

Discussion

The review highlights AI's transformative impact across various clinical prediction domains, including its role in revolutionising diagnostics, improving prognosis accuracy, aiding in personalised medicine, and enhancing patient safety. AI-driven tools contribute significantly to the efficiency and effectiveness of healthcare delivery.

Conclusion and recommendations

AI's integration in clinical prediction marks a substantial advancement in healthcare. Recommendations include enhancing data quality and accessibility, promoting interdisciplinary collaboration, focusing on ethical AI practices, investing in AI education, expanding clinical trials, developing regulatory oversight, involving patients in the AI integration process, and continuous monitoring and improvement of AI systems.